Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Steven Ades"'
Autor:
Abdullah Aloraini, Marc David, Dominique Frechette, Thierry Alcindor, Lorenzo E. Ferri, Monisha Sudarshan, M. Thirlwell, Steven Ades, Sonia Brisson, Marie van Huyse, Jamil Asselah
Publikováno v:
Annals of Surgical Oncology. 22:324-330
We have previously identified Docetaxel, Cisplatin, and 5FU (DCF) as a safe, tolerable, and effective regimen in the neoadjuvant setting for locally advanced adenocarcinoma (ADC) of the esophagus and esophagogastric junction (EGJ). We hypothesized th
Autor:
Martin Chasen, M.P. Thirlwell, Steven Ades, Victoria Marcus, Lorenzo E. Ferri, Thierry Alcindor, M. Hickeson, G. Artho
Publikováno v:
Annals of Oncology. 23:1512-1517
Background Although perioperative chemotherapy for esophagogastric adenocarcinoma (ADC) improves survival, the overall poor prognosis suggests that further refinement of treatment is required. Docetaxel, cisplatin, and 5-fluorouracil (5-FU) (DCF) is
Autor:
Steven Ades, Thierry Alcindor, Lorenzo E. Ferri, Jamil Asselh, Marc David, Marie Vanhuyse, Michael P. Thirlwell, Abdullah Aloraini
Publikováno v:
Journal of Clinical Oncology. 31:e15044-e15044
e15044 Background: We have previously identified Docetaxel, Cisplatin, and 5FU (DCF) as a highly effective regimen in the neoadjuvant setting for locally advanced adenocarcinoma (ADC) of the esophagus and esophago-gastric junction (EGJ). However ther
Autor:
Martin Chasen, Steven Ades, Thierry Alcindor, Lorenzo E. Ferri, Marc Hickeson, Victoria Marcus, Giovanni Artho, Michael P. Thirlwell
Publikováno v:
Journal of Clinical Oncology. 28:4075-4075
4075 Background: Docetaxel, cisplatin, and 5FU (DCF) has been shown to be an effective regimen for metastatic adenocarcinoma (ADC) of the foregut. We have completed accrual to a phase II trial of p...